Publication | Closed Access

Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease

Medicinal ChemistryAlzheimer's DiseaseEngineeringMedicinePharmacologyRational Drug DesignNeurochemical BiomarkersProtein MisfoldingMolecular DesignNovel HybridAdmet StudiesMolecular DockingMolecular ModelingBiophysicsDrug Discovery